Philadelphia, Pennsylvania--(Newsfile Corp. - May 31, 2026) - WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Zoetis, Inc. (NYSE: ZTS). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Zoetis, Inc. (NYSE: ZTS) shares prior to January 14, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/zoetis-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more. Alternatively, if you purchased Zoetis, Inc. shares between January 14, 2025 and May 6, 2026, you can participate in the class action.

WHY? As alleged by the City of Ann Arbor Retiree Health Care Benefit Plan & Trust in a recently filed securities fraud class action complaint, Zoetis, Inc. (NYSE: ZTS), through certain of its executives, violated federal securities laws by making false and/or misleading statements and/or failing to disclose that:: (i) veterinarian prescription growth and adoption of Zoetis' Librela, a canine pain treatment, were sharply weakening as clinicians became more cautious following FDA safety warnings concerning serious neurological complications in dogs;(ii) Zoetis' Simparica Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market;and(iii) Zoetis' dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment. Plaintiff alleges that the truth behind defendants' misrepresentations was revealed over the course of four disclosures spanning from August 5, 2025 to May 7, 2026. In the final disclosure on May 7, 2026, the Company reported first quarter 2026 financial results that reflected significant deterioration across its core Companion Animal business and sharply reduced its full-year guidance.

WHAT CAN YOU DO NOW? If you purchased Zoetis, Inc. (NYSE: ZTS) shares prior to January 14, 2025, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/zoetis-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Zoetis, Inc. shares between January 14, 2025 and May 6, 2026, you can participate in the class action.

#Zoetis #ZTS $ZTS

Attorney Advertising Disclaimer

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299556

Source: Grabar Law Office